Herein, we systematically characterized the role of CHCHD2 as a transcription factor by chromatin immunoprecipitation sequencing and found its target genes were enriched in nonalcoholic fatty liver disease (NAFLD). This evidence concerns the gene CHCHD2 and metabolic dysfunction-associated steatotic liver disease.